SinglePoint (Cboe:SING) CEO Releases Shareholder Letter Overviewing 2023 and Successful Listing on Cboe BZX Exchange

Successfully Uplisted to Cboe BZX Exchange December 15, 2023 Year to Date Revenue Crossing $30 million Completed $4,000,000 Underwritten Offering Capital Raise PHOENIX, AZ / ACCESSWIRE / December 21, 2023 / SinglePoint Inc. (Cboe:SING) a leading renewable solar energy and sustainable solutions provider releases shareholder letter overviewing 2023 and Successful listing on Cboe BZX Exchange. Dear […]

How Inspire Veterinary Partners’ (NASDAQ:IVP) Management System Is Helping Reinvent Veterinary Practice Management

VIRGINIA BEACH, VA / ACCESSWIRE / December 20, 2023 / Inspire Veterinary Partners Inc. (NASDAQ:IVP) has developed a unique management system for veterinary practices, departing from traditional models to emphasize a collaborative, employee-centered approach. This innovative system integrates the collective knowledge and experiences of a broad network of practices, aiming to enhance veterinary care efficiencies and foster […]

Volcon (NASDAQ: VLCN) ePowersports Operational Update for December 2023

AUSTIN, Texas, Dec. 20, 2023 (GLOBE NEWSWIRE) — Volcon Inc. (NASDAQ: VLCN) (“Volcon” or the “Company”), the first all-electric, off-road powersports company, shared operational updates today, including sales growth and an expansion of its distribution network during the holiday shopping season. The company has seen an increase in sales for its EVO and Volcon Youth […]

Mawson Infrastructure Group Inc. (NASDAQ:MIGI) Announces Monthly Operational Update for November 2023

November Total Revenue increased 47% M/M November Total Revenue of Bitcoin Equivalent of 132 BTC1 Completed Co-Location Customer Deployment of ~50 MW and ~15,876 miners Recently Signed Additional Co-Location Customer For ~6 MW and 1764 miners PITTSBURGH, Dec. 20, 2023 (GLOBE NEWSWIRE) — Mawson Infrastructure Group Inc. (NASDAQ:MIGI) (“Mawson” or the “Company”), a digital infrastructure company, announced […]

Longeveron (NASDAQ: LGVN) Announces $2.36 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

MIAMI, Dec. 21, 2023 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (HLHS), Alzheimer’s disease and Aging-related Frailty, today announced that it has entered into a definitive agreement for the issuance and sale […]

How Inspire Veterinary Partners (NASDAQ:IVP) Is Making Its Mark Through Its Approach To Strategic Leadership

VIRGINIA BEACH, VA / ACCESSWIRE / December 21, 2023 / Inspire Veterinary Partners Inc. (NASDAQ:IVP) is working hard to make its mark in the veterinary services industry. The company distinguishes itself through its team composition and management style, aimed at advancing veterinary practices. This article provides an overview of Inspire Veterinary Partners, focusing on its leadership, operational […]

SinglePoint (Cboe:SING) Announces Closing of $4 Million Public Offering, Uplisting to Cboe Global Markets and Reverse Stock Split

PHOENIX, AZ / ACCESSWIRE / December 19, 2023 / SinglePoint Inc. (Cboe:SING) (“SinglePoint” or the “Company”), a diversified holding company principally engaged through its subsidiaries in providing renewable energy solutions and energy-efficient applications to drive better health and living, today announced the closing of its underwritten public offering of 800,000 shares of common stock at a […]

Longeveron (NASDAQ: LGVN) Announces Additional Positive Clinical Data and Imaging Biomarker Results from the CLEAR MIND Phase 2a Trial of Lomecel-B™ in the Treatment of Mild Alzheimer’s Disease

New clinical data showed that Lomecel-B™ improved cognitive function in multiple measures in a dose-response fashion Caregiver ratings documented improved quality of life in Lomecel-B™ treated patients MRI Biomarker study data showed that Lomecel-B™ countered loss of brain volume in multiple areas associated with Alzheimer’s disease, reduced brain neuroinflammation and improved cerebral blood flow Overall results confirmed the […]

Start Expanding
Your Shareholder Base

Let us help you connect with investors
committed to your success.